酒精摄入与体重指数对肝硬化发病风险的交互作用
基于英国生物银行489,285名参与者的前瞻性队列研究,中位随访10.7人年,发现酒精摄入与肥胖均为肝硬化发病的独立危险因素,但二者对10年累积发病率无超相加交互作用。有害饮酒者在健康BMI下10年累积发病率是安全饮酒者的8.6倍,肥胖者仅为3.6倍。
要点
- 有害饮酒与肥胖均为肝硬化发病独立危险因素,但无超相加交互作用
- 健康BMI下有害饮酒者10年累积发病率是安全饮酒者的8.6倍
- 肥胖有害饮酒者相比健康BMI安全饮酒者10年超额累积发病率为1.83%
核心结论
- 酒精摄入和肥胖是肝硬化发病的独立危险因素,但二者对累积发病率无超相加交互作用。
研究设计与样本
- 基于英国生物银行489,285名无肝硬化住院史参与者的前瞻性队列研究,平均随访10.7人年。
- 主要结局为肝硬化发病的累积发病率,定义为首次因肝硬化住院,非肝硬化死亡作为竞争风险。
主要发现
- 共2070名参与者发生主要结局,10年粗累积发病率为0.36%(95%CI:0.34-0.38)。
- 健康BMI下,有害饮酒者10年累积发病率为1.38%,安全饮酒者为0.16%,比值8.6。
- 肥胖参与者中,有害饮酒者10年累积发病率为1.99%,安全饮酒者为0.56%,比值仅3.6。
- 相比健康BMI安全饮酒者,健康BMI有害饮酒者超额累积发病率为1.22%(95%CI:0.89-1.55),安全饮酒肥胖者为0.40%(95%CI:0.34-0.46),肥胖有害饮酒者为1.83%(95%CI:1.46-2.20)。
临床怎么用
- 临床评估肝硬化风险时,应同时关注酒精摄入和BMI,二者均为独立危险因素。
- 有害饮酒者即使BMI健康,肝硬化风险仍显著升高,需积极干预酒精摄入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: It is thought that alcohol intake and body mass index (BMI) interact supra-additively to modulate the risk of cirrhosis, but evidence for this phenomenon is limited. We investigated the interrelationship between alcohol and BMI on the incidence of cirrhosis morbidity for participants of the United Kingdom Biobank (UKB) study. APPROACH AND RESULTS: The primary outcome was the cumulative incidence of cirrhosis morbidity, defined as a first-time hospital admission for cirrhosis (with noncirrhosis mortality incorporated as a competing risk). All UKB participants without a previous hospital admission for cirrhosis were included in the analysis. We determined the ratio of the 10-year cumulative incidence in harmful drinkers versus safe drinkers according to BMI. We also calculated the excess cumulative incidence at 10 years for individuals with obesity and/or harmful alcohol compared to safe drinkers with a healthy BMI of 20-25.0 kg/m2 . A total of 489,285 UK Biobank participants were included, with mean of 10.7 person-years' follow-up. A total of 2070 participants developed the primary outcome, equating to a crude cumulative incidence of 0.36% at 10 years (95% CI:0.34-0.38). The 10-year cumulative incidence was 8.6 times higher for harmful (1.38%) versus safe drinkers (0.16%) if BMI was healthy. Conversely, it was only 3.6 times higher for obese participants (1.99% vs. 0.56%). Excess cumulative incidence was 1.22% (95% CI:0.89-1.55) for harmful drinkers with a healthy BMI, 0.40% (95% CI:0.34-0.46) for obese individuals drinking at safe levels, and 1.83% (95% CI:1.46-2.20) for obese harmful drinkers (all compared to safe drinkers with a healthy BMI). CONCLUSIONS: Alcohol intake and obesity are independent risk factors for cirrhosis morbidity, but they do not interact supra-additively to modulate the cumulative incidence of this outcome.
引用
- Innes H, Crooks CJ, Aspinall E, et al. Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity. Hepatology. 2021. PMID: 34453350. doi:10.1002/hep.32123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。